Basit öğe kaydını göster

Prognostic value of baseline Neutrophil to Lymphocyte Ratio (NLR) in metastatic Urothelial Carcinomas (mUC) patients (pts) treated with first-line chemotherapy (CT): A large retrospective multicenter study

dc.contributor.authorAuclin, E.
dc.contributor.authorOzguroglu, M.
dc.contributor.authorDujardin, C.
dc.contributor.authorTartour, E.
dc.contributor.authorOudard, S.
dc.contributor.authorGuven, S.
dc.contributor.authorAuvray, M.
dc.contributor.authorElaidi, R.
dc.contributor.authorGauthier, H.
dc.contributor.authorCuline, S.
dc.contributor.authorCaty, A.
dc.date.accessioned2021-03-03T16:59:01Z
dc.date.available2021-03-03T16:59:01Z
dc.identifier.citationAuvray M., Elaidi R., Ozguroglu M., Guven S., Gauthier H., Culine S., Caty A., Dujardin C., Auclin E., Tartour E., et al., "Prognostic value of baseline Neutrophil to Lymphocyte Ratio (NLR) in metastatic Urothelial Carcinomas (mUC) patients (pts) treated with first-line chemotherapy (CT): A large retrospective multicenter study", European Cancer Congress, Vienna, Avusturya, 01 Ocak 2015, cilt.51
dc.identifier.othervv_1032021
dc.identifier.otherav_474831a7-4738-4d20-a14a-222802009f10
dc.identifier.urihttp://hdl.handle.net/20.500.12627/51481
dc.identifier.urihttps://doi.org/10.1016/s0959-8049(16)31430-7
dc.language.isoeng
dc.subjectDahili Tıp Bilimleri
dc.subjectİç Hastalıkları
dc.subjectOnkoloji
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectONKOLOJİ
dc.titlePrognostic value of baseline Neutrophil to Lymphocyte Ratio (NLR) in metastatic Urothelial Carcinomas (mUC) patients (pts) treated with first-line chemotherapy (CT): A large retrospective multicenter study
dc.typeBildiri
dc.contributor.departmentİstanbul Üniversitesi , ,
dc.identifier.volume51
dc.contributor.firstauthorID147698


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster